Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009087/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is an open-label extension study in Alzheimer's patients who have completed
participation in either solanezumab Clinical Trial H8A-MC-LZAM (NCT00905372) or H8A-MC-LZAN
(NCT00904683).
提供机构：
Vivli
创建时间：
2023-07-06
